| European Case Law Identifier: | ECLI:EP:BA:1991:T044990.19911205 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 05 December 1991 | ||||||||
| Case number: | T 0449/90 | ||||||||
| Application number: | 83104642.0 | ||||||||
| IPC class: | A61K 35/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | |||||||||
| Download and more information: | 
 | ||||||||
| Title of application: | A method for the heat treatment of plasma, of plasma fractions and compositions obtained thereby | ||||||||
| Applicant name: | Cedars-Sinai Medical Center | ||||||||
| Opponent name: | 1) Central Blood Lab 2) Kabi Pharmacia AB 3) RORER Group, Inc. 4) Yamada, Hideo | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | 
 | ||||||||
| Keywords: | Amended Claims - allowable combination of features Sufficiency of disclosure - valid model tests disclosed by way of reference | ||||||||
| Catchwords: | - | ||||||||
| Cited decisions: | 
 | ||||||||
| Citing decisions: | 
 | ||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t900449eu1.html
Date retrieved: 17 May 2021
